It's one of the private players that CGOC has taken a stake in. Website says that they're focusing on the women's cannabis market. 40,000 sq ft facility in Northern Ontario, vertical integration (which is more of a buzzword in Canada than anything else with the branding rules, but it's a buzzword that investors want to hear even if a lot of them don't understand what it's actually supposed to mean).
"Phase 2" is to expand an additional 200,000 sq ft of growing space (on the same parcel of land near Kirkland Lake they're already on). Have a partnership with a Dutch company (There's the Europe buzzword) called Maripharm.
Their website hits on every current buzzword in marijuana investing, so either they're a really slick outfit that has been ahead of the curve for a while now and are going public, or they're an also ran Canadian LP trying to say the right things before IPO to drive up stock price so they can get a big ol bought deal to help them expand their production capacity before they get buried and forgotten.
CEO of Aphria has been pretty vocal in his belief that there will be space in the Canadian cannabis industry to craft grower producing excellent small batch product, so maybe this gang can do that (that's what they claim their Dutch partnership is largely about). I don't have a lot of faith in any small Canadian players who aren't damn close to built out on a legitimately sized growing space doing much in the future though.
On one hand I'm intrigued because CGOC is a stakeholder. But on the other hand, the private-public arbitrage play is a money maker for these types of firms (CGOC, Quinsam, etc) as long as the company isn't a complete ****ing flopshow right now. Just look at the Medmen IPO.
Thanks for the detailed update :thumbup1: